Vittal Vasista, Chief Financial Officer at REGENXBIO Inc. (RGNX), sold 45,624 shares at $50.01 ($2.3M) on 2020-12-23, disclosed to the SEC on 2020-12-28.
Open-market sale of $2.3M RGNX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.01 | 21,124 | $1.1M | 46.3% |
| 2 | $50.01 | 21,124 | $1.1M | 46.3% |
| 3 | $50.00 | 3,376 | $169K | 7.4% |
| Total | $50.01 avg | 45,624 | $2.3M | 100% |
| Filing → |
| RGNX | SELL | 2022-08-03 | $75K | — | Filing → |
| RGNX | SELL | 2022-07-15 | $274K | — | Filing → |
| RGNX | SELL | 2021-01-20 | $13K | — | Filing → |